SEC Form 3 · accession 0000899243-17-023312
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sumita Ray
Officer — See Remarks
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
SVP, GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER